Aura Biosciences, Inc. AURA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $84.79M+42.5% | $59.52M+25.2% | $47.55M-55.7% | $107.37M+181% | $38.23M+20.6% | ||
| $768K0.0% | $768K0.0% | $768K0.0% | $768K0.0% | $768K— | ||
| $3.77M-31.4% | $5.5M-33.4% | $8.25M+24.2% | $6.65M+1.9% | $6.53M-31.5% | ||
| $118.5M-20.9% | $149.74M-12.0% | $170.12M-7.5% | $183.96M+36.8% | $134.52M-16.3% | ||
| $2.47M-5.8% | $2.62M-0.2% | $2.63M-8.2% | $2.86M-7.9% | $3.11M-3.2% | ||
| $15.42M-2.6% | $15.83M-2.5% | $16.23M-2.4% | $16.62M-2.3% | $17.01M-2.2% | ||
| $517K+9.8% | $471K+70.0% | $277K+49.7% | $185K— | $0-100% | ||
| $137.68M-18.7% | $169.43M-10.8% | $190.02M-7.0% | $204.4M+31.5% | $155.4M-14.9% | ||
| $2.57M+66.1% | $1.55M-18.0% | $1.89M+46.8% | $1.29M-35.9% | $2.01M-12.9% | ||
| $3.27M+0.7% | $3.24M+0.7% | $3.22M+0.8% | $3.2M+0.8% | $3.17M+0.7% | ||
| $16.71M-9.1% | $18.38M-2.3% | $18.82M+26.7% | $14.85M+22.1% | $12.16M-18.4% | ||
| $13.72M-2.9% | $14.13M-2.8% | $14.53M-2.6% | $14.92M-2.3% | $15.27M-2.2% | ||
| $16.99M-2.2% | $17.38M-2.1% | $17.75M-2.0% | $18.11M-1.8% | $18.44M-1.7% | ||
| $30.43M-6.4% | $32.52M-2.5% | $33.36M+12.1% | $29.77M+8.5% | $27.44M-10.1% | ||
| $621.56M+0.7% | $617.43M+1.0% | $611.46M+1.3% | $603.33M+13.9% | $529.57M+0.7% | ||
| -$514.1M-7.0% | -$480.42M-5.6% | -$454.86M-6.1% | -$428.73M-6.7% | -$401.71M-7.3% | ||
| -$207K-103% | -$102K-248% | $69K+176% | $25K-76.2% | $105K-60.1% | ||
| $107.25M-21.7% | $136.91M-12.6% | $156.67M-10.3% | $174.63M+36.5% | $127.97M-15.8% | ||
| $137.68M-18.7% | $169.43M-10.8% | $190.02M-7.0% | $204.4M+31.5% | $155.4M-14.9% | ||
| $517K+9.8% | $471K+70.0% | $277K+49.7% | $185K— | $0-100% | ||
| $15.42M-2.6% | $15.83M-2.5% | $16.23M-2.4% | $16.62M-2.3% | $17.01M-2.2% | ||
| $15.42M-2.6% | $15.83M-2.5% | $16.23M-2.4% | $16.62M-2.3% | $17.01M-2.2% | ||
| $517K+9.8% | $471K+70.0% | $277K+49.7% | $185K— | $0-100% | ||
| $15.42M-2.6% | $15.83M-2.5% | $16.23M-2.4% | $16.62M-2.3% | $17.01M-2.2% | ||
| $517K+9.8% | $471K+70.0% | $277K+49.7% | $185K— | $0-100% | ||
| $10.87M-20.1% | $13.59M-0.9% | $13.72M+32.3% | $10.37M+48.5% | $6.99M-26.2% | ||
| $16.99M-2.2% | $17.38M-2.1% | $17.75M-2.0% | $18.11M-1.8% | $18.44M-1.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Aura Biosciences, Inc.'s total assets?
- Aura Biosciences, Inc. (AURA) holds $137.7M in total assets, down 11.4% year over year.
- How much debt does Aura Biosciences, Inc. have?
- Aura Biosciences, Inc. carries $17.0M in total debt against $107.2M of shareholders' equity, a debt-to-equity ratio of 0.16.
- How much cash does Aura Biosciences, Inc. have?
- Aura Biosciences, Inc. holds $84.8M in cash and equivalents.
- Can Aura Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 7.09 — current assets exceed current liabilities.
- Where does Aura Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.